Diatrizoate Meglumine And Diatrizoate Sodium Solution
Product Images NDC 53041-690

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Diatrizoate Meglumine And Diatrizoate Sodium (NDC 53041-690). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Guardian Drug Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

688120 (688 120ml)

Label of Diatrizoate Meglumine and Diatrizoate Sodium Solution USP for oral or rectal use, 120 mL bottle. Contains 660 mg diatrizoate meglumine and 100 mg diatrizoate sodium per mL. Manufactured by Guardian Drug Company. Label specifies single dose bottle, not for parenteral use, and includes storage and usage instructions.*

FDA Label Image

690120 (690 120ml)

Label for Diatrizoate Meglumine and Diatrizoate Sodium Solution USP, a 120 mL oral or rectal solution containing 660 mg/mL diatrizoate meglumine and 100 mg/mL diatrizoate sodium. The single-dose bottle is for gastrointestinal radiography and labeled Rx only. Manufactured by Guardian Drug Company, the label includes usage instructions, storage requirements, and safety warnings including 'Do Not Inject.'*

FDA Label Image

69030 (690 30ml)

Diatrizoate Meglumine and Diatrizoate Sodium Solution USP 30 mL single dose bottle label. Contains 660 mg diatrizoate meglumine and 100 mg diatrizoate sodium per mL, intended for oral or rectal use only. Manufactured by Guardian Drug Company. Label includes dosage, storage instructions, and a barcode.*

FDA Label Image

69030case (Caselabel30ml)

Label for Diatrizoate Meglumine and Diatrizoate Sodium Solution USP, 660 mg/mL and 100 mg/mL strengths, oral and rectal solution in 24 bottles of 30 mL each. Label indicates single dose bottles, storage instructions, manufacturer Guardian Drug Company, and warnings including 'Rx only' and 'Do Not Inject.'*

FDA Label Image

688120case (Shipper Label 120ml Pet)

Label for Diatrizoate Meglumine and Diatrizoate Sodium Solution USP, oral and rectal use, 660 mg/mL and 100 mg/mL strengths. The label indicates it contains 37% organically bound iodine, for gastrointestinal radiography only, single dose bottles, and not for parenteral use. It is manufactured by Guardian Drug Company, with storage and usage instructions, lot and expiration fields, barcode, and Guardian logo.*

FDA Label Image

690120case (Shipper Label 120ml)

Label for Diatrizoate Meglumine and Diatrizoate Sodium Solution USP, an oral and rectal solution containing 660 mg/mL diatrizoate meglumine and 100 mg/mL diatrizoate sodium. Packaged as 12 bottles of 120 mL each, manufactured by Guardian Drug Company. The label includes usage instructions and storage conditions, emphasizing that it is for radiographic use only and not for injection.*

FDA Label Image

111 (Structure1)

Chemical structure diagram of the active ingredients Diatrizoate Meglumine and Diatrizoate Sodium, depicting their molecular arrangements with labeled functional groups including carboxyl, hydroxyl, and amide components.*

FDA Label Image

112 (Structure2)

Chemical structure of Diatrizoate Meglumine and Diatrizoate Sodium, showing a benzene ring with iodine atoms and functional groups including carboxylate and amide moieties.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.